Anti-S100A14 monoclonal antibody
Pre-made anti-S100A14 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to S100A14/S100A14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2723-Ab-1/ GM-Tg-hg-IP2723-Ab-2 | Anti-Human S100A14 monoclonal antibody | Human |
GM-Tg-rg-IP2723-Ab-1/ GM-Tg-rg-IP2723-Ab-2 | Anti-Rat S100A14 monoclonal antibody | Rat |
GM-Tg-mg-IP2723-Ab-1/ GM-Tg-mg-IP2723-Ab-2 | Anti-Mouse S100A14 monoclonal antibody | Mouse |
GM-Tg-cynog-IP2723-Ab-1/ GM-Tg-cynog-IP2723-Ab-2 | Anti-Cynomolgus/ Rhesus macaque S100A14 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2723-Ab-1/ GM-Tg-felg-IP2723-Ab-2 | Anti-Feline S100A14 monoclonal antibody | Feline |
GM-Tg-cang-IP2723-Ab-1/ GM-Tg-cang-IP2723-Ab-2 | Anti-Canine S100A14 monoclonal antibody | Canine |
GM-Tg-bovg-IP2723-Ab-1/ GM-Tg-bovg-IP2723-Ab-2 | Anti-Bovine S100A14 monoclonal antibody | Bovine |
GM-Tg-equg-IP2723-Ab-1/ GM-Tg-equg-IP2723-Ab-2 | Anti-Equine S100A14 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2723-Ab-1/ GM-Tg-hg-IP2723-Ab-2; GM-Tg-rg-IP2723-Ab-1/ GM-Tg-rg-IP2723-Ab-2; GM-Tg-mg-IP2723-Ab-1/ GM-Tg-mg-IP2723-Ab-2; GM-Tg-cynog-IP2723-Ab-1/ GM-Tg-cynog-IP2723-Ab-2; GM-Tg-felg-IP2723-Ab-1/ GM-Tg-felg-IP2723-Ab-2; GM-Tg-cang-IP2723-Ab-1/ GM-Tg-cang-IP2723-Ab-2; GM-Tg-bovg-IP2723-Ab-1/ GM-Tg-bovg-IP2723-Ab-2; GM-Tg-equg-IP2723-Ab-1/ GM-Tg-equg-IP2723-Ab-2 |
Products Name | Anti-S100A14 monoclonal antibody |
Format | mab |
Target Name | S100A14 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-S100A14 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2723-Ag-1 | Recombinant multi-species S10AE/ S100A14/ BCMP84 protein |
ORF Viral Vector | pGMLP003841 | human S100A14 Lentivirus plasmid |
ORF Viral Vector | vGMLP003841 | human S100A14 Lentivirus particle |
Target information
Target ID | GM-IP2723 |
Target Name | S100A14 |
Gene ID | 57402,66166,685385,718338,612322,101082372,618250,100147656 |
Gene Symbol and Synonyms | 1110013O05Rik,BCMP84,S100A14,S100A15,S114 |
Uniprot Accession | Q9HCY8,Q3MHP3 |
Uniprot Entry Name | S10AE_HUMAN,S10AE_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000189334 |
Target Classification | N/A |
The target: S100A14, gene name: S100A14, also named as BCMP84, S100A15. This gene encodes a member of the S100 protein family which contains an EF-hand motif and binds calcium. The gene is located in a cluster of S100 genes on chromosome 1. Levels of the encoded protein have been found to be lower in cancerous tissue and associated with metastasis suggesting a tumor suppressor function (PMID: 19956863, 19351828). [provided by RefSeq, Dec 2011].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.